HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling

scientific article published in February 2015

HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10461-014-0936-3
P932PMC publication ID4352193
P698PubMed publication ID25398417
P5875ResearchGate publication ID268336424

P50authorHenry F RaymondQ56961711
Scott GeibelQ46612468
P2093author name stringAndrea A Kim
Nicholas Muraguri
Waimar Tun
Helgar Musyoki
Mercy Muthui
Dita Broz
Jerry Okal
Meredith Sheehy
P2860cites workA theme issue by, for, and about Africa: new injecting practice increases HIV risk among drug users in TanzaniaQ24536394
The rise of injecting drug use in East Africa: a case study from KenyaQ24816918
Estimates of the size of key populations at risk for HIV infection: men who have sex with men, female sex workers and injecting drug users in Nairobi, KenyaQ26822843
Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidenceQ28249288
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic reviewQ28295247
Global overview of injecting drug use and HIV infection among injecting drug users.Q31133757
Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase IIQ33235283
Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distributionQ33245178
HIV seroprevalence in a sample of Tanzanian intravenous drug usersQ33822369
Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networksQ34196455
HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programsQ34401872
Prevention of HIV infection among injection drug users in resource-limited settingsQ35043964
Correlates of HIV infection among young adult short-term injection drug users.Q50659913
Young and recent-onset injecting drug users are at higher risk for HIV.Q52275816
The nature of benzodiazepine dependence among heroin users in Sydney, Australia.Q52279297
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.Q55240560
Respondent-Driven Sampling II: Deriving Valid Population Estimates from Chain-Referral Samples of Hidden PopulationsQ56505051
Respondent-Driven Sampling: A New Approach to the Study of Hidden PopulationsQ56505053
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIVQ56961744
Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE studyQ35534549
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.Q35937711
Risk factors for human immunodeficiency virus infection in intravenous drug usersQ36154357
Polydrug abuse: a review of opioid and benzodiazepine combination useQ36266246
The role of sexual transmission of HIV infection among injection and non-injection drug usersQ36273534
HIV treatment as prevention and HPTN 052.Q36364604
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugsQ36390767
HIV infection among intravenous drug users: epidemiology and risk reduction.Q36433344
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patternsQ36689307
Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridgeQ36813560
Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examplesQ36958246
The impact of benzodiazepine use on methadone maintenance treatment outcomesQ37310406
Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysisQ37330136
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverageQ37699887
Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, NigeriaQ37846011
High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling surveyQ38489016
A rapid assessment of heroin use in Mombasa, KenyaQ38899297
HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, TanzaniaQ39758546
Prevalence and incidence of hepatitis C virus infection among young adult injection drug usersQ42680870
Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.Q42937874
Hepatitis C virus seroconversion among young injection drug users: relationships and risksQ43041146
Highly active antiretroviral therapy and survival in HIV-infected injection drug users.Q43903854
Harm reduction in Tanzania: an urgent need for multisectoral interventionQ43945524
Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug usersQ43946479
Heroin and HIV risk in Dar es Salaam, Tanzania: youth hangouts, mageto and injecting practices.Q43947715
The importance of preventing hepatitis C virus infection among injection drug users in the United States.Q44458986
HIV prevention among drug users: outcome of a network-oriented peer outreach interventionQ44562867
A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed?Q44676228
Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco.Q46399768
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)S24-35
P577publication date2015-02-01
P1433published inAIDS and BehaviorQ15752229
P1476titleHIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling
P478volume19 Suppl 1

Reverse relations

cites work (P2860)
Q55346664"Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
Q39036224Access to HIV treatment and care for people who inject drugs in Kenya: a short report
Q36837365An ethnographic exploration of drug markets in Kisumu, Kenya
Q47723455Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers
Q57297558Biometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerations
Q59336673Can HIV service data be used for surveillance purposes?: a case study in Guangzhou, China
Q37352481Commentary: the value of PrEP for people who inject drugs
Q64887689Depression, injecting drug use, and risky sexual behavior syndemic among women who inject drugs in Kenya: a cross-sectional survey.
Q64903561Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Q61798801HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data
Q93083224HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming
Q91611055High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
Q53688262Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities.
Q91789329Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science
Q35954772Lessons learned from respondent-driven sampling recruitment in Nairobi: experiences from the field
Q90431738Prevalence and determinants of unprotected sex in intimate partnerships of men who inject drugs: findings from a prospective intervention study
Q48148463Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users